The Pharmacy Industry in Levanger: Current Status and Future Prospects

The pharmacy industry in Levanger is a stable and important part of the local economy. In 2025, there are four registered pharmacy operations in the municipality, employing a total of 43 people and achieving revenue of 139 million NOK. The industry has shown positive development in recent years, with increasing revenue and stable employment numbers. The EBITDA margin is 4–7%, indicating good operational efficiency. There are no bankruptcy registrations among Levanger pharmacies, highlighting the industry's robustness.

Economic trends

Revenue and employees:

• Revenue: In 2025, Levanger pharmacies achieved combined revenue of 139 million NOK, an increase of 9.3% compared to 2024. While there have been variations in recent years, there is a clear upward trend since 2022.
• Employees: The number of employees has increased from 38 in 2023 to 43 in 2026, a 13% increase over four years. This shows gradual development in the industry, with growing focus on personal service and quality.

Operational results:

• EBITDA: Total EBITDA for the industry was 6.6 million NOK in 2025, with a margin of 4.8%. Some pharmacies have higher EBITDA margins (up to 7%), while others have lower (1%). This may be due to variations in cost structure and revenue growth.
• Gross margin: The industry has an extremely high gross margin of 11,036%, indicating strong business models with low variable costs relative to revenue.

Key players in the industry

The following pharmacy operations are registered in Levanger:

Organizational forms: All operations are registered as AS (limited liability company), indicating a standardized structure in the industry. This may provide advantages for stability and access to financing.

Geographic distribution of operations

All pharmacy operations in Levanger are located in the Levanger area, focusing on the following addresses:

• Magneten Kjøpesenter, Moafjæra 14 (two pharmacies)
• Helge Ingstads veg 1
• Håkon den godes gate 10

Municipal conditions: Levanger is located in Trøndelag, and pharmacies have access to stable infrastructure and a good transport network. This can be an advantage for both customers and suppliers.

Operational economic dynamics

Bankruptcy statistics: There are no bankruptcy registrations among Levanger pharmacies, indicating a stable industry with good operational efficiency.

Operational economic variations: Data shows that:

• Vitusapotek Magneten and Vitusapotek Levanger have higher EBITDA margins (6–7%) compared to Boots Apotek Magneten (1%).
• Apotek 1 Levanger had the highest revenue growth (10%) in 2025, while Boots Apotek Magneten had 0% growth in the same year.

Conclusion: The industry maintains a good balance between stability and variation in operational results, which can be an advantage for new entrants seeking to establish themselves.

Stable trends: The pharmacy industry in Levanger has shown positive development in recent years, with increasing revenue and stable employment numbers. This indicates a strong market for both existing and new players.

High margins: The extremely high gross margin (11,036%) shows that pharmacies have strong business models with low variable costs. This can be an advantage for entrepreneurs seeking to establish themselves in the municipality.

Development potential: With growing population and increased focus on health and quality of life, it may be possible to develop new pharmacies or offer specialized services in Levanger. There is also potential to explore collaboration with local health institutions and clinical services.

The pharmacy industry in Levanger is a stable and important part of the municipality's economy. With four operations, high margins, and good operational efficiency, it is an attractive market for both existing and new players. Future development will depend on the level of competition, business models, and local needs. SmartGrunder can help entrepreneurs find suitable addresses and develop strategies to establish themselves in this industry in Levanger.